Showing 4101-4110 of 10627 results for "".
New Products
https://reachmd.com/topics/skincare/new-products-7/35220/Coming & Going: July/August 2022
https://reachmd.com/topics/injectables/coming-going-july-august-2022/35196/Observations of a Medical Educator-Turned Patient
https://reachmd.com/programs/villanova_health_summit/observations-medical-educator-turned-patient/8078/Lawrence Sherman talks about innovative and collaborative interprofessional approaches to care.The Global Physician Workforce in the Army
https://reachmd.com/programs/the-strength-to-heal/the-global-physician-workforce-in-the-army/3238/The vast and diverse team of medical professionals serving in the United States Army comprises one of the world's few truly global healthcare systems. Col. Dr. John Powers, director of medical education for the U.S. Army, guides us through this expansive program, mobilized worldwide to care for ourCases From the Real World: 72-Year-Old Woman With CRVO
https://reachmd.com/programs/cme/Cases-From-the-Real-World-72-Year-Old-Woman-With-CRVO/33171/Hear how Drs. Ferhina Ali and Yasha Modi navigate the balance of extending treatment intervals while reducing the risk of recurrent ME in RVO.Cases From The Real World: A Long Battle With BRVO-ME
https://reachmd.com/programs/cme/Cases-From-The-Real-World-A-Long-Battle-With-BRVO-ME/33170/Join Drs. Yasha Modi and Ferhina Ali as they dive into the challenges of treating RVO-ME and the effectiveness of traditional and emerging agents.Understanding Dual Inhibition of IL-17
https://reachmd.com/programs/medical-industry-feature/understanding-dual-inhibition-of-il-17/32263/IL-17A and IL-17F play significant roles in rheumatic and psoriatic diseases as they trigger downstream pro-inflammatory responses.1,2 Targeting both IL-17A + IL-17F in vitro provides more inhibition of inflammation vs targeting IL-17A alone.*3-5 BIMZELX (bimekizumab-bkzx) is the only approved theraDeciphering IgA Nephropathy: Insights into the Diagnostic Process
https://reachmd.com/programs/frontlines-iga-nephropathy/deciphering-iga-nephropathy-insights-into-the-diagnostic-process/26946/When IgA nephropathy is suspected, it’s important to follow a stepwise pattern to confirm those suspicions. Here’s what the diagnostic process looks like.Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
https://reachmd.com/programs/gi-insights/recapping-the-2021-acg-clinical-guidelines-whats-new-in-colorectal-cancer-screening/13011/With so many different colorectal cancer screening options available, which is best for your patients based on the latest guidelines?New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
https://reachmd.com/clinical-practice/nephrology/new-data-from-the-confidence-trial-the-effect-of-combination-empagliflozin-and-finerenone-on-uacr-and-egfr-in-ckd-and-type-2-diabetes/39959/Stay current with the latest data from the CONFIDENCE trial. Dr. Heerspink explains how recent findings translate into clinical practice in this video brief.